Skip to Main Content

Author Details

Krushna C Patra
Harvard Medical School
2009
20
15
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36692000Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms.Elife2023
35173161A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis.Nat Commun2022
33815677BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis.World J Hepatol2021
32273287REDD1 loss reprograms lipid metabolism to drive progression of <i>RAS</i> mutant tumors.Genes Dev2020
30612899AMPK-Mediated Lysosome Biogenesis in Lung Cancer Growth.Cell Metab2019
31386860EGFR Pathway Links Amino Acid Levels and Induction of Macropinocytosis.Dev Cell2019
31109923TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.Cancer Discov2019
29687779Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation.Elife2018
29946147Author Correction: Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.Nat Commun2018
29920272A Cell Size Theory of Aging.Dev Cell2018
29941929Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.Nat Cell Biol2018
29871934<i>Kras</i> and <i>Tp53</i> Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma.Cancer Res2018
29386513Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.Nat Commun2018
28383565Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm.Clin Transl Gastroenterol2017
26190111Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration.Cell Rep2015
25037503The pentose phosphate pathway and cancer.Trends Biochem Sci2014
23610444DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.Cancer Res2013
24196563Hexokinase 2 as oncotarget.Oncotarget2013
23911236Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.Cancer Cell2013
19620286mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition.Mol Cell Biol2009
  • 1 - 20 of 20

Recommended Authors

The Rockefeller University
Career Start Year 2016
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2015
Number of shared co-authors 0
Moffitt Cancer Center and Research Institute
Career Start Year 2014
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
McGill University
Career Start Year 2013
Number of shared co-authors 0
Guangzhou University
Career Start Year 2013
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 1
Guangzhou University
Career Start Year 2009
Number of shared co-authors 0
Duke University
Career Start Year 2007
Number of shared co-authors 4
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 1
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
Career Start Year 2006
Number of shared co-authors 0
H. Lee. Moffitt Cancer Center
Career Start Year 2005
Number of shared co-authors 1
University of Southern California
Career Start Year 2004
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 2004
Number of shared co-authors 1
University of Nebraska Medical Center
Career Start Year 2004
Number of shared co-authors 0
Ben-Gurion University of the Negev
Career Start Year 2002
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2002
Number of shared co-authors 4
Institut Necker-Enfants Malades (INEM)
Career Start Year 2002
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 0
University of California san francisco
Career Start Year 1999
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 0
Robert Wood Johnson Medical School
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 6

Collaborators

Massachusetts General Hospital
Co-authored papers 9
Harvard Medical School
Co-authored papers 2
Geisel School of Medicine at Dartmouth and US Department of Veterans Affairs
Co-authored papers 2
Massachusetts Institute of Technology
Co-authored papers 2
University of California berkeley
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
University of Washington
Co-authored papers 1
College of Veterinary Medicine, Cornell University
Co-authored papers 1
University of Washington
Co-authored papers 1
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 1
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Washington
Co-authored papers 1
Elucidata Corporation
Co-authored papers 1
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
J. David Gladstone Institutes
Co-authored papers 1
J. David Gladstone Institutes
Co-authored papers 1